Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

1.030

+0.055 (5.67%)

At close: Sep 8, 2026, 4:00 PM EDT

1.020

-0.010 (-0.97%)

After-hours: Sep 8, 2026, 7:30 PM EDT

Akebia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	285	427	415	234	106	395
Market Cap Growth	-65.50%	3.06%	77.46%	120.08%	-73.16%	-2.30%
Enterprise Value	329	460	484	301	121	363
Last Close Price	0.97	1.61	1.90	1.24	0.58	2.26

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	82.56	18.72	18.72	18.72	18.72
PS Ratio	1.27	1.81	2.59	1.20	0.36	1.87
PB Ratio	10.59	13.10	-8.43	-7.64	20.30	5.34
P/FCF Ratio	6.92	6.31	-	-	-	-
P/OCF Ratio	6.70	6.28	-	-	-	-
PEG Ratio	-	2.23	2.23	2.23	2.23	2.23

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.47	1.95	3.02	1.55	0.41	1.71
EV/EBITDA Ratio	-	16.86	-	-	39.44	-
EV/EBIT Ratio	-	17.68	-	-	-	-
EV/FCF Ratio	8.00	6.79	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	7.96	6.10	-3.84	-4.72	30.07	2.56
Debt / EBITDA Ratio	220.34	6.16	-	-	18.82	-
Debt / FCF Ratio	4.95	2.94	-	-	-	-
Net Debt / Equity Ratio	1.74	0.43	-2.78	-3.31	12.77	0.53
Net Debt / EBITDA Ratio	-10.16	0.51	-15.73	-14.76	21.86	-0.21
Net Debt / FCF Ratio	1.08	0.21	-3.36	-4.33	-0.91	-0.15
Asset Turnover	0.63	0.79	0.69	0.65	0.66	0.36
Inventory Turnover	2.74	2.53	1.64	2.13	0.77	1.67
Quick Ratio	1.30	1.42	1.07	0.82	1.01	0.79
Current Ratio	1.43	1.55	1.41	1.18	1.43	1.04
Return on Equity (ROE)	-109.38%	-	-	-	-237.83%	-175.37%
Return on Assets (ROA)	-1.05%	5.44%	-12.49%	-9.30%	-4.89%	-24.27%
Return on Capital Employed (ROCE)	-3.10%	12.20%	-33.10%	-31.40%	-15.30%	-84.90%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-10.65%	-1.25%	-16.74%	-22.23%	-88.77%	-71.32%
FCF Yield	14.46%	15.85%	-9.82%	-10.01%	-69.03%	-63.99%
Buyback Yield / Dilution	-15.07%	-21.91%	-12.53%	-2.56%	-10.14%	-19.85%

SEC Filings: 10-K · 10-Q